An upregulation of phosphorylated HSP90β on Ser254 was seen post-anticancer treatment with 5-fluorocytosine, a prodrug used in tumor gene therapy treatment, highlighting that HSP90β might contribute to cancer regression (110). The gene discussed is HSP90AB1; the disease is cancer.